Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints Jeff Capello as executive VP and CFO

He will lead the company's business and finance planning functions

Jeff CapelloBiotechnology company Biogen has appointed Jeff Capello as its executive vice president and chief financial officer, roles which will see him lead the company’s business planning, tax, treasury, internal audit, accounting and investor relations functions.

Reporting to chief executive officer of Biogen, Michel Vounatsos, Capello will also become a member of the executive committee and he will be based in its Massachusetts office in the US.

He said: “I am very excited to join Biogen, a company which is recognised as a pioneer and a leader in treating neurological diseases and I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

Capello brings 26 years of experience in finance to Biogen, with his most recent role being executive vice president and chief financial officer at Beacon Health Options.

His career experience has seen him serve in various positions for Monomy Advisors, Ortho Clinical Diagnostics, Boston Scientific Corporation and Perkin Elmer.

Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.

“He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

5th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics